Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma (Q42952825)

11 November 2017

title

Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma (English)

1 reference

11 November 2017

1 reference

1 reference

11 November 2017

Raphaël Maréchal

1 reference

11 November 2017

John R Mackey

1 reference

11 November 2017

Raymond Lai

1 reference

11 November 2017

Pieter Demetter

1 reference

11 November 2017

Marc Polus

1 reference

11 November 2017

Carol E Cass

1 reference

11 November 2017

Isabelle Salmon

1 reference

11 November 2017

Jacques Devière

1 reference

11 November 2017

Jean-Luc Van Laethem

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

11 November 2017

1 reference

11 November 2017

volume

116

1 reference

11 November 2017

1 reference

11 November 2017

page(s)

5200-5206

1 reference

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

The intracellular localization of deoxycytidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Immunocytochemical detection of deoxycytidine kinase in haematological malignancies and solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Mammalian deoxyribonucleoside kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Deoxycytidine is salvaged not only into DNA but also into phospholipid precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Deoxycytidine is salvaged not only into DNA but also into phospholipid precursors. III. dCOP-diacylglycerol formation in tonsillar lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

inferred from DOI database lookup

7 January 2021

based on heuristic

Maximizing therapeutic gain with gemcitabine and fractionated radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

inferred from DOI database lookup

7 January 2021

based on heuristic

Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.25303

1 reference

11 November 2017

1 reference